Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 4/2009

01-04-2009 | Original Paper

Socio-demographic characteristics of participation in the opportunistic German cervical cancer screening programme: results from the EPIC-Heidelberg cohort

Authors: David Seidel, Nikolaus Becker, Sabine Rohrmann, Katharina Nimptsch, Jakob Linseisen

Published in: Journal of Cancer Research and Clinical Oncology | Issue 4/2009

Login to get access

Abstract

Objective

To analyse participation in the German cervical cancer screening programme by socio-demographic characteristics.

Methods

In the EPIC-Heidelberg cohort study 13,612 women aged 35–65 years were recruited between 1994 and 1998. Follow-up questionnaires were used to analyse participation in cervical cancer screening. Subjects were categorised according to age (birth cohort), education, vocational training, employment status, marital status and household size. Associations between socio-demographic characteristics and participation in cervical cancer screening were analysed using multinomial logistic regression.

Results

Females of the oldest and middle birth cohort were less likely to be screened compared to the youngest birth cohort. Less-educated women and those with a low-level secondary school degree had a decreased likelihood of undergoing screening in comparison to better educated women. Married women and women living in households with four or more persons were more likely to participate in the screening programme than single women or women living alone. Employment status did not modify participation in cervical cancer screening.

Conclusions

Knowledge on the characteristics of women with a lower attendance to cervical cancer screening could be used to improve the effectiveness of the current (opportunistic) programme by dedicated health promotion programmes. However, an organized screening programme with written invitation of all eligible women would be the preferred option.
Footnotes
1
Low-level secondary school form of 5 years.
 
2
Medium-level secondary school form of 6 years.
 
3
High-level secondary school form of 8–9 years; qualifies for admission to technical college/university.
 
4
Can be attended after graduation from Gymnasium with at least 8 years of education.
 
5
Can be attended after graduation from Gymnasium.
 
Literature
go back to reference Anttila A, Nieminen P (2000) Cervical cancer screening programme in Finland. Eur J Cancer 36:2209–2214PubMedCrossRef Anttila A, Nieminen P (2000) Cervical cancer screening programme in Finland. Eur J Cancer 36:2209–2214PubMedCrossRef
go back to reference Becker N (2003) Epidemiological aspects of cancer screening in Germany. J Cancer Res Clin Oncol 129:691–702PubMedCrossRef Becker N (2003) Epidemiological aspects of cancer screening in Germany. J Cancer Res Clin Oncol 129:691–702PubMedCrossRef
go back to reference Becker N, Wahrendorf J (1998) Atlas of Cancer Mortality in Germany 1981–1990, 3rd edn. Springer, Berlin Becker N, Wahrendorf J (1998) Atlas of Cancer Mortality in Germany 1981–1990, 3rd edn. Springer, Berlin
go back to reference Boeing H, Korfmann A, MM Bergmann, Recruitment procedures of EPIC-Germany (1999a) European Investigation into Cancer and Nutrition. Ann Nutr Metab 43:205–215PubMedCrossRef Boeing H, Korfmann A, MM Bergmann, Recruitment procedures of EPIC-Germany (1999a) European Investigation into Cancer and Nutrition. Ann Nutr Metab 43:205–215PubMedCrossRef
go back to reference Boeing H, Wahrendorf J, Becker N (1999b) EPIC-Germany—a source for studies into diet and risk of chronic diseases. Ann Nutr Metab 43:195–204PubMedCrossRef Boeing H, Wahrendorf J, Becker N (1999b) EPIC-Germany—a source for studies into diet and risk of chronic diseases. Ann Nutr Metab 43:195–204PubMedCrossRef
go back to reference Coughlin SS, King J, Richards TB, Ekwueme DU (2006) Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiol Biomarkers Prev 15:2154–2159PubMedCrossRef Coughlin SS, King J, Richards TB, Ekwueme DU (2006) Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiol Biomarkers Prev 15:2154–2159PubMedCrossRef
go back to reference Doll R, Payne P, Waterhouse J (1966) Cancer incidence in five continents. A technical report. International Union Against Cancer. Springer, Berlin Doll R, Payne P, Waterhouse J (1966) Cancer incidence in five continents. A technical report. International Union Against Cancer. Springer, Berlin
go back to reference European Commission (2008) European guidelines for quality assurance in cervical cancer screening, 2nd edn. European Commission, Brussels European Commission (2008) European guidelines for quality assurance in cervical cancer screening, 2nd edn. European Commission, Brussels
go back to reference Gordon NP, Hiatt RA, Lampert DI (1993) Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst 85:566–570PubMedCrossRef Gordon NP, Hiatt RA, Lampert DI (1993) Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst 85:566–570PubMedCrossRef
go back to reference Hakama M, Miller AB, Day NE (1986). Screening for cancer of the uterine cervix. IARC Scientific Publications No. 76. IARC, Lyon Hakama M, Miller AB, Day NE (1986). Screening for cancer of the uterine cervix. IARC Scientific Publications No. 76. IARC, Lyon
go back to reference IARC (2005) Cervic cancer screening. IARC handbooks of cancer prevention, vol 10. International Agency for Research on Cancer, Lyon IARC (2005) Cervic cancer screening. IARC handbooks of cancer prevention, vol 10. International Agency for Research on Cancer, Lyon
go back to reference Klug SJ, Hetzer M, Blettner M (2005) Screening for breast and cervical cancer in a large German city: participation, motivation and knowl edge of risk factors. Eur J Public Health 15:70–77PubMedCrossRef Klug SJ, Hetzer M, Blettner M (2005) Screening for breast and cervical cancer in a large German city: participation, motivation and knowl edge of risk factors. Eur J Public Health 15:70–77PubMedCrossRef
go back to reference Rebolj M, van Ballegooijen M, Berkers L-M, Habbema D (2006) Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int J Cancer 120:806–812CrossRef Rebolj M, van Ballegooijen M, Berkers L-M, Habbema D (2006) Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int J Cancer 120:806–812CrossRef
go back to reference Riboli E, Kaaks R (1997) The Epic project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26:6–14CrossRef Riboli E, Kaaks R (1997) The Epic project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26:6–14CrossRef
go back to reference Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR et al (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113–1124PubMedCrossRef Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR et al (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113–1124PubMedCrossRef
go back to reference RKI (Robert-Koch-Institute), GEKID (Society of the epidemiological cancer registries in Germany) (2008) Cancer in Germany 2003–2004 (in German). 6. revised version, Berlin RKI (Robert-Koch-Institute), GEKID (Society of the epidemiological cancer registries in Germany) (2008) Cancer in Germany 2003–2004 (in German). 6. revised version, Berlin
go back to reference Rodvall Y, Kemetli L, Tishelman C, Törnberg S (2005) Factors related to participation in a cervical cancer screening programme in urban Sweden. Eur J Cancer Prev 14:459–466PubMedCrossRef Rodvall Y, Kemetli L, Tishelman C, Törnberg S (2005) Factors related to participation in a cervical cancer screening programme in urban Sweden. Eur J Cancer Prev 14:459–466PubMedCrossRef
go back to reference Scheffer S, Dauven S, Sieverding M (2006) Sociodemographic differences in the participation in “early detection of cancer examinations” in Germany—a review. Gesundheitswesen 68:139–146PubMedCrossRef Scheffer S, Dauven S, Sieverding M (2006) Sociodemographic differences in the participation in “early detection of cancer examinations” in Germany—a review. Gesundheitswesen 68:139–146PubMedCrossRef
go back to reference Taylor RJ, Mamoon HA, Morrell SL, Wain GV (2001) Cervical screening by socio-economic status in Australia. Aust N Z J Public Health 25:256–260PubMedCrossRef Taylor RJ, Mamoon HA, Morrell SL, Wain GV (2001) Cervical screening by socio-economic status in Australia. Aust N Z J Public Health 25:256–260PubMedCrossRef
Metadata
Title
Socio-demographic characteristics of participation in the opportunistic German cervical cancer screening programme: results from the EPIC-Heidelberg cohort
Authors
David Seidel
Nikolaus Becker
Sabine Rohrmann
Katharina Nimptsch
Jakob Linseisen
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 4/2009
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-008-0485-0

Other articles of this Issue 4/2009

Journal of Cancer Research and Clinical Oncology 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.